Half-Life

The time required for the concentration of a compound to decrease by 50%, a key pharmacokinetic parameter in peptide research.

Reference / Full Definition

Biological Mechanisms

Half-life (t½) is the time required for the plasma concentration of a compound to decrease by half through metabolism and elimination. It is a fundamental pharmacokinetic parameter that influences dosing frequency in research protocols.

Peptide half-lives vary enormously: unmodified small peptides may have half-lives of minutes, while engineered compounds like semaglutide achieve approximately 7-day half-lives through fatty acid albumin-binding modifications. Tesamorelin's N-terminal hexenoic acid modification extends its half-life compared to native GHRH.

All Healthy Aminos products are for research use only.

Cross-Reference / Related Products

Semaglutide Tesamorelin Ipamorelin

Cross-Reference / Related Terms

BioavailabilityThe fraction of an administered compound that reaches systemic circulation in an active form, influenced by route of administration and molecular properties.Receptor AgonistA molecule that binds to and activates a receptor, mimicking the action of the natural ligand to initiate a signaling response.AcetylationThe addition of an acetyl group (CH3CO-) to the N-terminus of a peptide, commonly used to increase metabolic stability.

Back to Glossary

Research Use Only

FOR RESEARCH USE ONLY. Products sold by Healthy Aminos are intended strictly for in-vitro research and laboratory use. Not for human or animal consumption. Not FDA approved. By purchasing from Healthy Aminos, the buyer acknowledges that these products are not intended to diagnose, treat, cure, or prevent any disease. All products are sold as reference standards and research chemicals only.